Form 4 for IRMD IRADIMED CORP
Accepted 2025-10-07 00:00:00 ET · period of report 2025-10-06 · accession 0001613801-25-000017 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-10-07 | 2025-10-06 | IRMD | Susi Roger E. | CEO, Pres, COB, Dir, 10% | S - Sale | $71.72 | -5,000 | 2.34M | -0.2% | -$358.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-06 | S | D | 4,800 | $71.70 | 2,342,700 | I By Phillip Susi 2008 Dynasty Trust | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $71.25 to $72.21. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2025-10-06 | S | D | 200 | $72.27 | 2,342,500 | I By Phillip Susi 2008 Dynasty Trust | — | — |